translocates to the nucleus and promotes dauer arrest through transcriptional regulation 3,4 . In 43 a genetic screen for suppressors of the dauer-constitutive phenotype of an eak-7;akt-1 double 44 mutant strain that exhibits reduced DAF-2/InsR signaling and increased DAF-16/FoxO 45 activity 5-8 , we isolated a strain containing a ~3.5 kb deletion, dpDf665, that spanned the trap-46
The mechanistic basis for the biogenesis of peptide hormones and growth factors is 22 poorly understood. Here we show that the conserved endoplasmic reticulum (ER) membrane 23 translocon-associated protein (TRAP) , also known as signal sequence receptor 1 (SSR1) 1 , 24 plays a critical role in the biosynthesis of insulin. A genetic screen in the nematode 25
Caenorhabditis elegans revealed trap-1, which encodes the C. elegans TRAP ortholog, as a 26 modifier of DAF-2 insulin receptor (InsR) signaling. Genetic analysis indicates that TRAP-1 27 acts upstream of DAF-2/InsR to control C. elegans development. Endogenous C. elegans 28 TRAP-1 and mammalian TRAP both localized to the ER. In pancreatic beta cells, TRAP 29 deletion impaired preproinsulin translocation but did not affect the synthesis of 1-30 antitrypsin, indicating that TRAP selectively influences the translocation of a subset of 31 secreted proteins. Surprisingly, loss of TRAP function also resulted in disruption of distal 32 steps in insulin biogenesis including proinsulin processing and secretion. These results show 33 that TRAP assists in the ER translocation of preproinsulin and unveil unanticipated 34 additional consequences of TRAP loss-of-function on the intracellular trafficking and 35 maturation of proinsulin. The association of common intronic single nucleotide variants in 36 the human TRAP gene with susceptibility to Type 2 diabetes and pancreatic beta cell 37 dysfunction 2 suggests that impairment of preproinsulin translocation and proinsulin 38 trafficking may contribute to the pathogenesis of Type 2 diabetes. 39
The C. elegans DAF-2/InsR pathway prevents dauer diapause through a conserved 40 phosphoinositide 3-kinase (PI3K)/Akt pathway that inhibits the FoxO transcription factor 41 DAF- 16 . In the context of reduced DAF-2/InsR signaling, cytoplasmic DAF-16/FoxO 42 independent trap-1 null mutations ( Figure S1 ) phenocopied the dpDf665 deletion ( Figure   48 1B), whereas a null mutation in Y71F9AL.1 did not ( Figure S2 ), indicating that the mutant 49 phenotype is a consequence of trap-1 deletion. trap-1 mutation suppressed the dauer-50 constitutive phenotype of mutants with reduced DAF-2/InsR signaling ( Figure 1C ) but not 51 the phenotype of mutants with reduced signaling in other pathways that inhibit dauer 52 diapause 3,9 ( Figure S3 ). Furthermore, trap-1 mutation impaired the induction of DAF- TRAP-1 is orthologous to mammalian TRAP/SSR1 (henceforth referred to as 56 "TRAP"), a transmembrane ER protein identified based on its interaction with the 57 preprolactin signal peptide during in vitro protein translocation 1,11 ( Figure S4 ). TRAP 58 physically associates with three other conserved ER transmembrane proteins (TRAP, 59  and ) to form the TRAP complex 12 . A functional single-copy TRAP-1::mCherry fusion 60 protein generated by CRISPR/Cas9-mediated knock-in ( Figure 1C ) is expressed in several 61 tissues in C. elegans embryos, larvae, and adult animals (Figures 2A-C). Coexpression of 62 TRAP-1::mCherry with the ER protein signal peptidase fused to GFP 13 revealed that 63 endogenous TRAP-1 localizes to the ER ( Figure 2D ). 64
Although the biological function of mammalian TRAP has not been established, it is 65 thought to play a role in cotranslational ER translocation based on its interaction with the 66 preprolactin signal peptide in vitro 11 , its necessity for the in vitro translocation of prion 67 protein 14 , and its physical proximity to the Sec61 protein translocation channel [15] [16] [17] [18] [19] . As the 68 expanded C. elegans insulin-like gene family encodes 40 peptides, some of which enhance 69 dauer arrest by antagonizing DAF-2/InsR signaling 20,21 , we hypothesized that TRAP-1 70 influences DAF-2/InsR signaling by promoting the ER-based biosynthesis of one or more of 71 these insulin-like negative regulators of DAF-2/InsR 20 . If this model is correct, then DAF-72 2/InsR mutations that impair receptor function downstream of ligand binding should be 73 resistant to suppression by trap-1 mutation, as these mutant DAF-2/InsR receptors would be 74 refractory to changes in ligand-mediated activity caused by trap-1 mutation. We therefore 75 tested the effect of trap-1 mutation on the dauer-constitutive phenotype of eight distinct daf-76 2/InsR loss-of-function alleles, seven of which affect amino acid residues that are conserved 77 in the human InsR 22 (Table S1 ). 78
Whereas trap-1 mutation suppressed the dauer-constitutive phenotype of the daf-2 79 alleles e1368 and m212 ( Figure S5A and Table S1 ), both of which encode receptors with 80 missense mutations in the extracellular ligand-binding domain 22,23 , the dauer-constitutive 81 phenotypes of the other six daf-2 alleles were not affected by trap-1 mutation. The functional 82 consequences of four of these six DAF-2/InsR mutations can be inferred from data on human 83
InsRs with point mutations affecting the corresponding conserved residues (Table S1) . A 84 heterozygous mutation in the human InsR kinase domain corresponding to daf-2(e1391) 23 85 was found in a patient with autosomal dominant Type A insulin-resistant diabetes mellitus 86 with acanthosis nigricans (IRAN) 24 and results in a severe reduction in InsR in vitro kinase 87 activity and autophosphorylation 25 . Another Type A IRAN patient was found to be 88 homozygous for a missense mutation in the InsR extracellular domain corresponding to daf-89 2(m579) 26 that reduces the affinity of InsR for insulin by three-to-five fold 27 . A missense 90 mutation affecting the conserved residue in the human InsR corresponding to the glycine 91 mutated in daf-2(m596) was identified in a patient with insulin resistance and 92 leprechaunism 28 and reduces the amount of InsR present at the plasma membrane by more 93 than 90% 29 . Finally, human InsR harboring a missense mutation affecting the conserved 94 cysteine mutated in daf-2(m577) 22 exhibits a 100-fold reduction in levels of mature 95 tetrameric receptor present at the cell surface compared to wild-type human InsR 30 . The 96 failure of trap-1 mutation to suppress the dauer-constitutive phenotypes of these daf-2/InsR 97 alleles ( Figure S5A and Table S1 ) indicates that TRAP-1 acts upstream of DAF-2/InsR and is 98 consistent with a role for TRAP-1 in the biogenesis of insulin-like peptide ligands that 99
To further test the hypothesis that TRAP-1 promotes the biogenesis of antagonistic 101 DAF-2/InsR ligands, we determined the effect of trap-1 mutation on the dauer-constitutive 102 phenotype of animals with mutations in three genes encoding DAF-2/InsR agonist peptides 21 . 103 trap-1 mutation partially suppressed the dauer-constitutive phenotype of ins-4 ins-6;daf-28 104 triple mutants ( Figure S5B ), consistent with a model whereby TRAP-1 promotes antagonist 105 insulin-like peptide ligand action. 106
As human insulin antagonizes DAF-2/InsR signaling when it is expressed in C.
107
elegans 20 , we explored the possibility that mammalian TRAP promotes insulin biogenesis.
108
Endogenous TRAP colocalized with KDEL ER resident proteins but not with the Golgi 109 marker GM130 31 in rat INS 832/13 pancreatic beta cells ( Figure 3A ). To assess the role of 110 TRAP in preproinsulin translocation, we generated INS 832/13 cells lacking TRAP using 111 CRISPR/Cas9-based genome editing. Normally, preproinsulin is nearly undetectable by 112 immunoblotting with anti-proinsulin antibodies ( Figure 3B These data could be consistent with a requirement for TRAP in the translocation of 117 preproinsulin such that in the absence of TRAP, untranslocated preproinsulin is degraded 118 by the proteasome. Alternatively, the data in Figure 3B could be consistent with impaired 119 preproinsulin processing by signal peptidase in the ER. To distinguish between a 120 translocation defect and a signal peptidase processing defect in TRAP KO cells, we 121 determined the protease sensitivity of preproinsulin in TRAP KO cells after selective 122 permeabilization of the plasma membrane ( Figure 3C ). In wild-type cells, preproinsulin was 123 fully translocated into the ER and processed to proinsulin that was protease-resistant after 124 plasma membrane permeabilization with digitonin but degraded after full solubilization of 125 internal membranes with Triton X-100 ( Figure 3C , third and fourth lanes). In TRAP KO 126 cells, accumulated preproinsulin was protease-sensitive both after partial as well as complete 127 membrane permeabilization ( Figure 3C 
proteins. 163
We also used immunofluorescence to independently examine the consequences of 164 TRAP KO on insulin biogenesis. In wild-type cells, insulin ( Figure 4A ) and proinsulin 165 ( Figure 4B ) were readily detectable. However, TRAP KO resulted in a dramatic decrease in 166 insulin content ( Figure 4A ), although proinsulin was still detectable ( Figure 4B) . 167
Reintroducing epitope-tagged TRAP into TRAP KO cells rescued insulin production in 168 transfected cells (Figures 4C-D), and infection of TRAP KO cells with adenovirus encoding 169
TRAP at increasing multiplicities of infection revealed that this rescue was dose-dependent 170 ( Figure S7) . 171
Our finding that TRAP activity is required for efficient insulin biogenesis and 172 secretion was unexpected. Defects in proinsulin processing and secretion could be an indirect 173 consequence of TRAP dysfunction in the ER. In mouse fibroblasts, TRAP physically 174 associates with misfolded ER-associated degradation (ERAD) substrates 32 , suggesting that 175 TRAP may play a role in reducing ER stress. Thus, in pancreatic beta cells, loss of TRAP 176 may cause abnormalities in proinsulin processing and secretion ( Figures 3F-H) due to a 177 general increase in ER stress. 178
To determine whether C. elegans TRAP-1 and mammalian TRAP play roles in 179 mitigating ER stress, we assayed for constitutive activation of the unfolded protein response 180 in animals and beta cells lacking TRAP-1 or TRAP, respectively. In C. elegans, 181 transcription of hsp-4, which encodes a homolog of the human ER chaperone BiP, is induced 182 by ER stress 33 . Indeed, while green fluorescence was not detectable in wild-type hsp-4::GFP 183 reporter animals grown under normal culture conditions, it was readily visualized in trap-1 184 mutant animals harboring the same transgene ( Figure 4E) . Similarly, increased 185 phosphorylation of eIF2 at serine 51, which is phosphorylated by PERK in response to ER 186 stress 34 , was detected in INS 832/13 cells with reduced TRAP expression but not in wild-187 type INS 832/13 cells ( Figure 4F ). Thus, we cannot exclude the possibility that TRAP may 188 indirectly influence distal events in insulin biogenesis through effects on ER stress that are 189 not similarly consequential for 1-antitrypsin ( Figures 3I-J) . mutant strains were constructed using conventional methods. trap-1 mutant alleles were 416 generated using CRISPR/Cas9-based genome editing 1 . Two guide RNAs complementary to 417 sequences in exon 2 were used. Molecular analysis of trap-1 mutants is described in Figure   418 S1. DNA encoding a mCherry epitope tag was inserted in-frame at the 3' end of the trap-1 419 open reading frame using CRISPR/Cas9-based homology-directed genome editing as 420 described 2 . Red fluorescent animals were isolated, and the mCherry insertion was verified by 421
Sanger sequencing of PCR products spanning the insertion site. 422 423 Genetic screen for modifiers of C. elegans DAF-2/InsR signaling: The suppressor of eak-424 7;akt-1 (seak) screen was performed by mutagenizing eak-7;akt-1 double mutants with N-425 ethyl-N-nitrosourea (ENU) and screening for rare animals in the F2 generation that did not 426 arrest as dauers as described 3 . Genomic DNA isolated from eak-7;akt-1 suppressor strains was 427 sequenced and analyzed as described 3 . 428 429 Dauer arrest assays: Dauer arrest assays were performed at 25°C as previously described 4 . 430
431
Real-time quantitative PCR (qPCR): qPCR was performed as previously described 5 . 432
